AGTT yields 2857.14% · JNJ yields 2.13%● Live data
📍 AGTT pulled ahead of the other in Year 1
Combined, AGTT + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of AGTT + JNJ for your $10,000?
Angstrom Technologies, Inc. provides UV fluorescent chemicals and electronic detection systems. It offers solutions for security, fraud deterrence, and brand protection, as well as process control, and track and trace for manufacturing. The company's UV fluorescent chemical products include invisible fluorescent chemicals, daylight fluorescent chemicals, phosophorescent chemicals, and inks/varnishes for security, research, process control, and entertainment purposes. It also provides chemistry services. The company's electronic detection systems comprise fluorescence detection systems; system accessories and UV lights; and MoneyChecker, a device used for verifying US currency and other documents at a point of sale or office environment. It serves government organizations, companies, and financial institutions. The company was incorporated in 1983 and is based in Florence, Kentucky.
Full AGTT Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.